Home>Topics>Finance>Ceos>David Pyott

David Pyott

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
  1. Allergan's (AGN) CEO David Pyott on Q2 2014 Results - Earnings Call Transcript

    Headlines

    Mon, 21 Jul 2014

    Q2 2014 Earnings Conference Call July 21, 2014, 10:30 AM ET Executives Jim Hindman - SVP, Treasury, Risk & IR David Pyott - Chairman & CEO Jeff Edwards - EVP, Finance & Business Development, CFO Scott Whitcup - EVP, R&D, Chief Scientific

  2. New Morningstar Analyst Report for Allergan Inc

    Stock Reports

    Wed, 2 Jul 2014

    management possesses impressive research and development acumen, which supports long-term growth opportunities. David Pyott , having held his position since 1998, follows as another long-serving CEO. Pyott previously headed the nutrition

  3. Allergan plans to raise earnings outlook: CEO

    Headlines

    Mon, 23 Jun 2014

    SAN DIEGO (Reuters) - Allergan Inc , seeking to win over shareholders as it fights a hostile takeover offer from Valeant Pharmaceuticals International Inc , will raise its earnings outlook when it reports second-quarter results, said Chief Executive Officer David Pyott .

  4. Who Is Telling The Truth On Fillers: Valeant's CEO Or Allergan's CEO? Is Valeant's Debt A Time-Bomb?

    Headlines

    Mon, 23 Jun 2014

    Michael Pearson, the CEO of Valeant, claims that his fillers gained market share. At the same time, Allergan's CEO, David Pyott , says Valeant lost filler market share dramatically. Here are their respective quotes. Michael Pearson from Valeant's

  5. Allergan CEO undaunted by likely long battle with Valeant

    Headlines

    Tue, 10 Jun 2014

    its ally, hedge fund billionaire William Ackman."I'm an endurance player; I climbed Kilmanjaro last year," David Pyott said in a telephone interview, when asked if he was prepared to battle Valeant and Ackman possibly into next year

  6. From Barron’s, December 30, 2013 (Part 2)

    Commentary

    Sat, 28 Dec 2013

    BRK-A/B, DIS, GPS, JNJ, MCK, PAYX, PEP, PFE, PM, UNP ; pg 34]; Allergan [ AGN ; the CEO spotlight on David Pyott ; pg 36]. KO story http://online.barrons.com/article/SB50001424053111904742804579282313576005116.html

« Prev12Next »
Content Partners